⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3869822 | 0.79 | — | — | |
| SCHEMBL845124 | 0.72 | — | — | |
| SCHEMBL5521944 | 0.69 | — | — | |
| SCHEMBL5892717 | 0.69 | — | — | |
| SCHEMBL9891729 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL866239 | 0.69 | — | — | |
| SCHEMBL1536343 | 0.69 | — | — | |
| SCHEMBL14552664 | 0.69 | — | — | |
| SCHEMBL4616294 | 0.69 | — | — | |
| SCHEMBL7603902 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637456-B2 | Process for preparing methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl} carbamate | ADVERIO PHARMA GMBH (DE) | 2026-05-26 | — | — | US | disclosed |
| CN-119954802-A | Process for preparing compounds | 阿德弗里奥药品有限责任公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119954803-A | Process for preparing compounds | 阿德弗里奥药品有限责任公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-115697978-B | Process for preparing methyl {4, 6-diamino-2- [ 5-fluoro-1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b ] pyridin-3-yl ] pyrimidin-5-yl } carbamate | 阿德弗里奥药品有限责任公司 | 2025-02-28 | — | — | CN | disclosed |
| WO-2024254601-A1 | HPGD INHIBITORS AND USES THEREOF | NIMBUS DISCOVERY, INC. (US) | 2024-12-12 | — | — | WO | disclosed |
| US-20230219952-A1 | PROCESS FOR PREPARING METHYL {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3 -YL]PYRIMIDIN-5-YL} CARBAMATE | ADVERIO PHARMA GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| EP-4165028-A1 | PROCESS FOR PREPARING METHYL {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}CARBAMATE | Adverio Pharma GmbH (DE) | 2023-04-19 | — | — | EP | disclosed |
| CN-115697978-A | Method for preparing methyl {4,6-diamino-2- [ 5-fluoro-1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b ] pyridin-3-yl ] pyrimidin-5-yl } carbamate | 阿德弗里奥药品有限责任公司 | 2023-02-03 | — | — | CN | disclosed |
| WO-2021254981-A1 | PROCESS FOR PREPARING METHYL {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}CARBAMATE | ADVERIO PHARMA GMBH (DE) | 2021-12-23 | — | — | WO | disclosed |
| EP-3925953-A1 | PROCESS FOR PREPARING METHYL {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}CARBAMATE | Adverio Pharma GmbH (DE) | 2021-12-22 | — | — | EP | disclosed |
| WO-2002020558-A2 | METHOD FOR BINDING, IN SOLUTION, A PEPTIDE AND A LIPOPHILIC VECTOR AND USES THEREOF | INSTITUT PASTEUR DE LILLE (FR) | 2002-03-14 | — | — | WO | disclosed |
| WO-2001009173-A2 | USE OF QUINIC, SHIKIMIC ACIDS AND THEIR DERIVATIVES FOR PREPARING MANNOSE RECEPTOR LIGANDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNR S) (FR) | 2001-02-08 | — | — | WO | disclosed |
| US-6140361-A | FOR INHIBITING BINDING OF HUMAN IMMUNODEFICIENCY VIRUS REV PROTEIN TO REV RESPONSIVE ELEMENTS (RRE) | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-10-31 | — | — | US | disclosed |
| US-5942547-A | FOR INHIBITING BINDING OF HUMAN IMMUNODEFICIENCY VIRUS PROTEIN TO RESPONSIVE ELEMENT; TREATMENT OF AIDS | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0865283-A1 | 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPACIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Scriptgen Pharmaceuticals Inc. (US) | 1998-09-23 | — | — | EP | disclosed |
| WO-1997009053-A9 | 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPATIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF | — | 1997-05-01 | — | — | WO | disclosed |
| EP-0767791-A1 | ARYL, ALKYL, ALKENYL AND ALKYNYLMACROLIDES HAVING IMMUNOSUPPRESSIVE ACTIVITY | MERCK & CO. INC. (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1997009053-A1 | 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPATIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1997-03-13 | — | — | WO | disclosed |
| US-5550233-A | AUTOIMMUNE DISEASES; PREVENTION OF TRANSPLANT REJECTION | MERCK & CO., INC. (US) | 1996-08-27 | — | — | US | disclosed |
| WO-1995035299-A1 | ARYL, ALKYL, ALKENYL AND ALKYNYLMACROLIDES HAVING IMMUNOSUPPRESSIVE ACTIVITY | MERCK & CO., INC. (US) | 1995-12-28 | — | — | WO | disclosed |